Heterogeneity of humoral immune response to Leishmania tropica in an experimental model
- PMID: 30778754
- DOI: 10.1007/s00436-019-06256-3
Heterogeneity of humoral immune response to Leishmania tropica in an experimental model
Abstract
Humoral (antibody) response is an important part of immunity against pathogens. Despite the clear role of cell-mediated immune response in protection against leishmaniasis, the role of humoral responses is challenging. There is very limited data regarding humoral immune response against Leishmania tropica which is the causative agent of human cutaneous leishmaniasis in many parts of the world. Here, we have compared pathogenicity and antibody response against six Iranian Leishmania tropica isolates in BALB/c mice. A Leishmania major isolate was used for comparison. The parasites were injected into the mice followed by the evaluation of the lesion development, parasite load, and antibody responses (IgG1 and IgG2a). Our findings showed that some isolates caused the large lesions and high parasite load in the spleen and lymph node, while other isolates led to no lesion, no splenic parasitism, and low parasite load in the lymph node. The more pathogenic isolates induced higher antibody responses (IgG1 and IgG2a). Our results indicated that there is substantial heterogeneity among various Leishmania tropica isolates regarding the humoral immune response as well as the pathogenicity.
Keywords: Antibody; Iran; Leishmania tropica; Lesion size; Parasite load.
Similar articles
-
Leishmania tropica: suggestive evidences for the effect of infectious dose on pathogenicity and immunogenicity in an experimental model.Parasitol Res. 2018 Sep;117(9):2949-2956. doi: 10.1007/s00436-018-5991-7. Epub 2018 Jul 5. Parasitol Res. 2018. PMID: 29978420
-
Lower levels of IgG1 in comparison with IgG2a are associated with protective immunity against Leishmania tropica infection in BALB/c mice.J Microbiol Immunol Infect. 2017 Apr;50(2):160-166. doi: 10.1016/j.jmii.2015.05.007. Epub 2015 May 14. J Microbiol Immunol Infect. 2017. PMID: 26066544
-
Molecular epidemiology of cutaneous leishmaniasis and heterogeneity of Leishmania major strains in Iran.Trop Med Int Health. 2012 Nov;17(11):1335-44. doi: 10.1111/j.1365-3156.2012.03078.x. Epub 2012 Sep 4. Trop Med Int Health. 2012. PMID: 22947226
-
Distinct immunological states in murine cutaneous leishmaniasis by immunising with different amounts of antigen: the generation of beneficial, potentially harmful, harmful and potentially extremely harmful states.Behring Inst Mitt. 1997 Feb;(98):153-9. Behring Inst Mitt. 1997. PMID: 9382736 Review.
-
Experimental cutaneous leishmaniasis: Langerhans cells internalize Leishmania major and induce an antigen-specific T-cell response.Adv Exp Med Biol. 1993;329:587-92. doi: 10.1007/978-1-4615-2930-9_98. Adv Exp Med Biol. 1993. PMID: 8379429 Review. No abstract available.
Cited by
-
Nanostructured Lipid Carriers as Robust Systems for Lupeol Delivery in the Treatment of Experimental Visceral Leishmaniasis.Pharmaceuticals (Basel). 2023 Nov 23;16(12):1646. doi: 10.3390/ph16121646. Pharmaceuticals (Basel). 2023. PMID: 38139773 Free PMC article.
-
Effect of Vigna radiata, Tamarix ramosissima and Carthamus lanatus extracts on Leishmania major and Leishmania tropica: An in vitro study.Chin Herb Med. 2020 Mar 5;12(2):171-177. doi: 10.1016/j.chmed.2019.12.006. eCollection 2020 Apr. Chin Herb Med. 2020. PMID: 36119795 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources